| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 0 | 0 | 84.755 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 0 | 3.159 | 116.482 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 45 | 1.656 | 114.248 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 0 | -45 | 1.503 | 2.234 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 0 | -45 | 1.250 | 1.877 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 7 |
Check the financial reports for the company - Primordium Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 27.902 | 33.165 | 180.164 | 171.111 |
| Current Assets | - | - | - | - | - | - | 106 | 5 | 4.093 | 16.619 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 3.404 | 8.085 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 0 | 526 |
| Cash | - | - | - | - | - | - | 106 | 5 | 689 | 8.008 |
| Shareholders Funds | - | - | - | - | - | - | 101 | 56 | 1.306 | 3.176 |
| Social Capital | - | - | - | - | - | - | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | - | - | 27.907 | 33.114 | 182.951 | 184.553 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Primordium Med S.r.l.